Natalie Pankova
Chief Operating Officer @ Metadvice
London, United Kingdom
Natalie Pankova is a seed investor at Metadvice in London focused on Therapeutics and Biotechnology. Dr Natalie Pankova is the Chief Operating Officer at Metadvice, a digital health startup building artificial intelligence - driven clinical decision software to enable doctors and pharma executives combine the avalanche of newly available medical information into real time decision making. Dr Pankova holds a PhD from the Faculty of Medicine,University of Toronto, has worked as a scientist and executive in pharma, biotech and healthtech companies. She has led operations in drug discovery and development, health technology and machine learning, building novel technologies from the ground up, and understands the massive problems facing the healthcare landscape, the ways that technology is poised to challenge the status quo of these systems, and the complex journeys startups face in this space. She previously led healthcare efforts at the Government Blockchain Association in the UK, participated in technology initiatives within the Pharmaceutical Users Exchange Group (PhUSE), All-Party Parliamentary Groups at the UK Parliament, Research Data Alliance, and the British Standards Institute. She is a Digital Health Expert at the World Health Organization, an Associate Lecturer at Claude Littner Business School, and is on the Editorial Board of Frontiers in Blockchain Journal, as well as an Advisor and Mentor to early stage innovative startups.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Natalie Pankova invests in
Stages Natalie Pankova invests in
Countries Natalie Pankova invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Health Care 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Pre-Seed 1 (50%)
Country
- United States 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SignaCor
|
SignaCor is a clinical-stage biotech company exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy. | $331.9K / Seed / Mar 09, 2026 | |
Cellestial Health
|
Cellestial Health creates best-in-class, safe small molecule medicines that protect often-overlooked networks of brain cells known as astrocytes, halting the progression of Parkinson's disease and other neurological illnesses. | $656.3K / Pre-Seed / Dec 06, 2024 |
Co-Investors
About Metadvice
Metadvice Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Natalie Pankova
Chief Operating Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Natalie Pankova invest in?
Natalie Pankova invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Natalie Pankova?
Public channels for Natalie Pankova include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Natalie Pankova last invest?
The most recent investment recorded for Natalie Pankova closed in Mar 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
